#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=5 .
1-1	0-1	5	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Adipose Tissue Inflammation during Aging
2-1	4-11	Adipose	abstract|abstract[4]	new|new[4]	coref|coref|coref|coref	3-1|3-15[10_4]|3-1|3-15[10_4]
2-2	12-18	Tissue	object|abstract[4]	new|new[4]	_	_
2-3	19-31	Inflammation	abstract[4]	new[4]	_	_
2-4	32-38	during	_	_	_	_
2-5	39-44	Aging	_	_	_	_

#Text=Adipose tissue plays an essential role in age-related metabolic dysfunction and is linked to systemic , chronic , and low-grade inflammation .
3-1	45-52	Adipose	abstract|object[6]	giv|new[6]	coref|coref|coref|coref	5-1|5-2[0_6]|5-1|5-2[0_6]
3-2	53-59	tissue	object[6]	new[6]	_	_
3-3	60-65	plays	_	_	_	_
3-4	66-68	an	abstract[7]	new[7]	_	_
3-5	69-78	essential	abstract[7]	new[7]	_	_
3-6	79-83	role	abstract[7]	new[7]	_	_
3-7	84-86	in	abstract[7]	new[7]	_	_
3-8	87-98	age-related	abstract[7]|abstract[9]	new[7]|new[9]	coref	11-12[99_9]
3-9	99-108	metabolic	abstract[7]|abstract|abstract[9]	new[7]|new|new[9]	_	_
3-10	109-120	dysfunction	abstract[7]|abstract[9]	new[7]|new[9]	_	_
3-11	121-124	and	_	_	_	_
3-12	125-127	is	_	_	_	_
3-13	128-134	linked	_	_	_	_
3-14	135-137	to	_	_	_	_
3-15	138-146	systemic	abstract[10]	giv[10]	coref	4-18[14_10]
3-16	147-148	,	abstract[10]	giv[10]	_	_
3-17	149-156	chronic	abstract[10]	giv[10]	_	_
3-18	157-158	,	abstract[10]	giv[10]	_	_
3-19	159-162	and	abstract[10]	giv[10]	_	_
3-20	163-172	low-grade	abstract[10]	giv[10]	_	_
3-21	173-185	inflammation	abstract[10]	giv[10]	_	_
3-22	186-187	.	_	_	_	_

#Text=Aging is associated with a decline in immune competence referred to as immunosenescence , which leads to chronic , low-grade inflammation named “ inflammaging ” .
4-1	188-193	Aging	_	_	_	_
4-2	194-196	is	_	_	_	_
4-3	197-207	associated	_	_	_	_
4-4	208-212	with	_	_	_	_
4-5	213-214	a	abstract[11]	new[11]	_	_
4-6	215-222	decline	abstract[11]	new[11]	_	_
4-7	223-225	in	abstract[11]	new[11]	_	_
4-8	226-232	immune	abstract[11]|abstract[12]	new[11]|new[12]	_	_
4-9	233-243	competence	abstract[11]|abstract[12]	new[11]|new[12]	_	_
4-10	244-252	referred	_	_	_	_
4-11	253-255	to	_	_	_	_
4-12	256-258	as	_	_	_	_
4-13	259-275	immunosenescence	abstract	new	coref	5-47
4-14	276-277	,	_	_	_	_
4-15	278-283	which	_	_	_	_
4-16	284-289	leads	_	_	_	_
4-17	290-292	to	_	_	_	_
4-18	293-300	chronic	abstract[14]	giv[14]	coref	5-3[0_14]
4-19	301-302	,	abstract[14]	giv[14]	_	_
4-20	303-312	low-grade	abstract[14]	giv[14]	_	_
4-21	313-325	inflammation	abstract[14]	giv[14]	_	_
4-22	326-331	named	_	_	_	_
4-23	332-333	“	_	_	_	_
4-24	334-346	inflammaging	plant	new	_	_
4-25	347-348	”	_	_	_	_
4-26	349-350	.	_	_	_	_

#Text=Adipose tissue inflammation results in the release of pro-inflammatory cytokines such as TNF-α , IL-1b , IL-6 and monocyte chemoattractant protein ( MCP-1/CCL2 ) from adipose tissue macrophages , and these factors are also associated to the presence of senescent cells ( p16INK4A ) leading to immunosenescence .
5-1	351-358	Adipose	abstract|abstract[19]	giv|new[19]	coref|coref	5-26|5-26
5-2	359-365	tissue	object|abstract[19]	giv|new[19]	coref	5-27
5-3	366-378	inflammation	abstract|abstract[19]	giv|new[19]	coref	6-24[47_0]
5-4	379-386	results	abstract[19]	new[19]	_	_
5-5	387-389	in	abstract[19]	new[19]	_	_
5-6	390-393	the	abstract[19]|event[20]	new[19]|new[20]	_	_
5-7	394-401	release	abstract[19]|event[20]	new[19]|new[20]	_	_
5-8	402-404	of	abstract[19]|event[20]	new[19]|new[20]	_	_
5-9	405-421	pro-inflammatory	abstract[19]|event[20]|abstract[21]	new[19]|new[20]|new[21]	coref	6-8[0_21]
5-10	422-431	cytokines	abstract[19]|event[20]|abstract[21]	new[19]|new[20]|new[21]	_	_
5-11	432-436	such	abstract[19]|event[20]	new[19]|new[20]	_	_
5-12	437-439	as	abstract[19]|event[20]	new[19]|new[20]	_	_
5-13	440-445	TNF-α	abstract[19]|event[20]|event|abstract[23]	new[19]|new[20]|new|new[23]	coref|coref|coref|coref	8-31|14-28[134_23]|8-31|14-28[134_23]
5-14	446-447	,	abstract[19]|event[20]|abstract[23]	new[19]|new[20]|new[23]	_	_
5-15	448-453	IL-1b	abstract[19]|event[20]|abstract[23]|event	new[19]|new[20]|new[23]|new	_	_
5-16	454-455	,	abstract[19]|event[20]|abstract[23]	new[19]|new[20]|new[23]	_	_
5-17	456-460	IL-6	abstract[19]|event[20]|abstract[23]|event	new[19]|new[20]|new[23]|new	coref	8-26
5-18	461-464	and	abstract[19]|event[20]|abstract[23]	new[19]|new[20]|new[23]	_	_
5-19	465-473	monocyte	abstract[19]|event[20]|abstract[23]|substance[27]	new[19]|new[20]|new[23]|new[27]	coref	17-19[0_27]
5-20	474-489	chemoattractant	abstract[19]|event[20]|abstract[23]|object|substance[27]	new[19]|new[20]|new[23]|new|new[27]	_	_
5-21	490-497	protein	abstract[19]|event[20]|abstract[23]|substance[27]	new[19]|new[20]|new[23]|new[27]	_	_
5-22	498-499	(	_	_	_	_
5-23	500-510	MCP-1/CCL2	object	new	_	_
5-24	511-512	)	_	_	_	_
5-25	513-517	from	_	_	_	_
5-26	518-525	adipose	abstract|object[31]	giv|new[31]	coref|coref|coref|coref	6-4[38_31]|6-18|6-4[38_31]|6-18
5-27	526-532	tissue	object|object[31]	giv|new[31]	coref	6-17[44_0]
5-28	533-544	macrophages	object[31]	new[31]	_	_
5-29	545-546	,	_	_	_	_
5-30	547-550	and	_	_	_	_
5-31	551-556	these	abstract[32]	new[32]	coref	17-34[179_32]
5-32	557-564	factors	abstract[32]	new[32]	_	_
5-33	565-568	are	_	_	_	_
5-34	569-573	also	_	_	_	_
5-35	574-584	associated	_	_	_	_
5-36	585-587	to	_	_	_	_
5-37	588-591	the	abstract[33]	new[33]	_	_
5-38	592-600	presence	abstract[33]	new[33]	_	_
5-39	601-603	of	abstract[33]	new[33]	_	_
5-40	604-613	senescent	abstract[33]|object[34]	new[33]|new[34]	appos	5-43[0_34]
5-41	614-619	cells	abstract[33]|object[34]	new[33]|new[34]	_	_
5-42	620-621	(	_	_	_	_
5-43	622-630	p16INK4A	object	giv	coref	12-16[106_0]
5-44	631-632	)	_	_	_	_
5-45	633-640	leading	_	_	_	_
5-46	641-643	to	_	_	_	_
5-47	644-660	immunosenescence	abstract	giv	coref	12-9
5-48	661-662	.	_	_	_	_

#Text=The exposure of macrophages to hormones , cytokines , chemokines , and fatty acids found within dysfunctional adipose tissue stimulates them to adopt a pro-inflammatory phenotype inflammation .
6-1	663-666	The	abstract[37]	new[37]	_	_
6-2	667-675	exposure	abstract[37]	new[37]	_	_
6-3	676-678	of	abstract[37]	new[37]	_	_
6-4	679-690	macrophages	abstract[37]|object[38]	new[37]|giv[38]	coref	7-22[58_38]
6-5	691-693	to	abstract[37]|object[38]	new[37]|giv[38]	_	_
6-6	694-702	hormones	abstract[37]|object[38]|substance	new[37]|giv[38]|new	_	_
6-7	703-704	,	abstract[37]|object[38]	new[37]|giv[38]	_	_
6-8	705-714	cytokines	abstract[37]|object[38]|abstract	new[37]|giv[38]|giv	coref	8-31[73_0]
6-9	715-716	,	abstract[37]|object[38]	new[37]|giv[38]	_	_
6-10	717-727	chemokines	abstract[37]|object[38]|substance	new[37]|giv[38]|new	_	_
6-11	728-729	,	abstract[37]|object[38]	new[37]|giv[38]	_	_
6-12	730-733	and	abstract[37]|object[38]	new[37]|giv[38]	_	_
6-13	734-739	fatty	abstract[37]|object[38]|substance[42]	new[37]|giv[38]|new[42]	ana	6-21[0_42]
6-14	740-745	acids	abstract[37]|object[38]|substance[42]	new[37]|giv[38]|new[42]	_	_
6-15	746-751	found	_	_	_	_
6-16	752-758	within	_	_	_	_
6-17	759-772	dysfunctional	object[44]	giv[44]	coref	7-3[0_44]
6-18	773-780	adipose	abstract|object[44]	giv|giv[44]	coref	7-2
6-19	781-787	tissue	object[44]	giv[44]	_	_
6-20	788-798	stimulates	_	_	_	_
6-21	799-803	them	substance	giv	_	_
6-22	804-806	to	_	_	_	_
6-23	807-812	adopt	_	_	_	_
6-24	813-814	a	abstract[47]	giv[47]	coref	7-1[50_47]
6-25	815-831	pro-inflammatory	abstract[47]	giv[47]	_	_
6-26	832-841	phenotype	abstract|abstract[47]	new|giv[47]	_	_
6-27	842-854	inflammation	abstract[47]	giv[47]	_	_
6-28	855-856	.	_	_	_	_

#Text=Age-associated adipose tissue inflammation is related to the activation of the NFκB signaling pathway , with promotes a pro-inflammatory polarization of adipose tissue macrophages , independent from total adipose tissue mass .
7-1	857-871	Age-associated	abstract[50]	giv[50]	coref	16-29[159_50]
7-2	872-879	adipose	abstract|abstract[50]	giv|giv[50]	coref	7-22
7-3	880-886	tissue	object|abstract[50]	giv|giv[50]	coref	7-23
7-4	887-899	inflammation	abstract[50]	giv[50]	_	_
7-5	900-902	is	_	_	_	_
7-6	903-910	related	_	_	_	_
7-7	911-913	to	_	_	_	_
7-8	914-917	the	abstract[51]	new[51]	coref	12-12[0_51]
7-9	918-928	activation	abstract[51]	new[51]	_	_
7-10	929-931	of	abstract[51]	new[51]	_	_
7-11	932-935	the	abstract[51]|abstract[54]	new[51]|new[54]	_	_
7-12	936-940	NFκB	abstract[51]|abstract|abstract[54]	new[51]|new|new[54]	coref	14-43
7-13	941-950	signaling	abstract[51]|abstract|abstract[54]	new[51]|new|new[54]	coref	10-29[90_0]
7-14	951-958	pathway	abstract[51]|abstract[54]	new[51]|new[54]	_	_
7-15	959-960	,	_	_	_	_
7-16	961-965	with	_	_	_	_
7-17	966-974	promotes	_	_	_	_
7-18	975-976	a	abstract[55]	new[55]	coref	8-4[64_55]
7-19	977-993	pro-inflammatory	abstract[55]	new[55]	_	_
7-20	994-1006	polarization	abstract[55]	new[55]	_	_
7-21	1007-1009	of	abstract[55]	new[55]	_	_
7-22	1010-1017	adipose	abstract[55]|abstract|object[58]	new[55]|giv|giv[58]	coref|coref|coref|coref	7-29|12-2[0_58]|7-29|12-2[0_58]
7-23	1018-1024	tissue	abstract[55]|object|object[58]	new[55]|giv|giv[58]	coref	7-30
7-24	1025-1036	macrophages	abstract[55]|object[58]	new[55]|giv[58]	_	_
7-25	1037-1038	,	_	_	_	_
7-26	1039-1050	independent	_	_	_	_
7-27	1051-1055	from	_	_	_	_
7-28	1056-1061	total	quantity[61]	new[61]	_	_
7-29	1062-1069	adipose	abstract|quantity[61]	giv|new[61]	coref	8-34
7-30	1070-1076	tissue	object|quantity[61]	giv|new[61]	coref	8-34[75_0]
7-31	1077-1081	mass	quantity[61]	new[61]	_	_
7-32	1082-1083	.	_	_	_	_

#Text=The stimulus for age-associated macrophage pro-inflammatory polarization can be associated with endoplasmic reticulum stress , which promotes a pro-inflammatory environment due to the release of IL-6 , MCP-1 , and TNF-α cytokines within adipose tissue .
8-1	1084-1087	The	abstract[62]	new[62]	_	_
8-2	1088-1096	stimulus	abstract[62]	new[62]	_	_
8-3	1097-1100	for	abstract[62]	new[62]	_	_
8-4	1101-1115	age-associated	abstract[62]|abstract[64]	new[62]|giv[64]	_	_
8-5	1116-1126	macrophage	abstract[62]|place|abstract[64]	new[62]|new|giv[64]	coref	9-14
8-6	1127-1143	pro-inflammatory	abstract[62]|abstract[64]	new[62]|giv[64]	_	_
8-7	1144-1156	polarization	abstract[62]|abstract[64]	new[62]|giv[64]	_	_
8-8	1157-1160	can	_	_	_	_
8-9	1161-1163	be	_	_	_	_
8-10	1164-1174	associated	_	_	_	_
8-11	1175-1179	with	_	_	_	_
8-12	1180-1191	endoplasmic	abstract|abstract[67]	new|new[67]	coref|coref	11-6[0_67]|11-6[0_67]
8-13	1192-1201	reticulum	abstract|abstract[67]	new|new[67]	_	_
8-14	1202-1208	stress	abstract[67]	new[67]	_	_
8-15	1209-1210	,	_	_	_	_
8-16	1211-1216	which	_	_	_	_
8-17	1217-1225	promotes	_	_	_	_
8-18	1226-1227	a	abstract[68]	new[68]	coref	16-4[150_68]
8-19	1228-1244	pro-inflammatory	abstract[68]	new[68]	_	_
8-20	1245-1256	environment	abstract[68]	new[68]	_	_
8-21	1257-1260	due	_	_	_	_
8-22	1261-1263	to	_	_	_	_
8-23	1264-1267	the	event[69]	new[69]	coref	13-6[120_69]
8-24	1268-1275	release	event[69]	new[69]	_	_
8-25	1276-1278	of	event[69]	new[69]	_	_
8-26	1279-1283	IL-6	event[69]|abstract	new[69]|giv	coref	14-32
8-27	1284-1285	,	event[69]	new[69]	_	_
8-28	1286-1291	MCP-1	event[69]|substance	new[69]|new	_	_
8-29	1292-1293	,	event[69]	new[69]	_	_
8-30	1294-1297	and	event[69]	new[69]	_	_
8-31	1298-1303	TNF-α	event[69]|abstract|abstract[73]	new[69]|giv|giv[73]	coref|coref	14-28|14-28
8-32	1304-1313	cytokines	event[69]|abstract[73]	new[69]|giv[73]	_	_
8-33	1314-1320	within	event[69]|abstract[73]	new[69]|giv[73]	_	_
8-34	1321-1328	adipose	event[69]|abstract[73]|abstract|object[75]	new[69]|giv[73]|giv|giv[75]	coref|coref|coref|coref	9-12|9-13[0_75]|9-12|9-13[0_75]
8-35	1329-1335	tissue	event[69]|abstract[73]|object[75]	new[69]|giv[73]|giv[75]	_	_
8-36	1336-1337	.	_	_	_	_

#Text=The decreased vascularization promoted by aging promotes local hypoxia and favors adipose tissue macrophage accumulation .
9-1	1338-1341	The	abstract[76]	new[76]	_	_
9-2	1342-1351	decreased	abstract[76]	new[76]	_	_
9-3	1352-1367	vascularization	abstract[76]	new[76]	_	_
9-4	1368-1376	promoted	_	_	_	_
9-5	1377-1379	by	_	_	_	_
9-6	1380-1385	aging	abstract	new	coref	16-10
9-7	1386-1394	promotes	_	_	_	_
9-8	1395-1400	local	abstract[78]	new[78]	_	_
9-9	1401-1408	hypoxia	abstract[78]	new[78]	_	_
9-10	1409-1412	and	_	_	_	_
9-11	1413-1419	favors	_	_	_	_
9-12	1420-1427	adipose	abstract|abstract[82]	giv|new[82]	coref|coref|coref|coref	12-5|13-1[117_82]|12-5|13-1[117_82]
9-13	1428-1434	tissue	object|abstract[82]	giv|new[82]	coref	12-4[102_0]
9-14	1435-1445	macrophage	place|abstract[82]	giv|new[82]	_	_
9-15	1446-1458	accumulation	abstract[82]	new[82]	_	_
9-16	1459-1460	.	_	_	_	_

#Text=The macrophage infiltration is perpetuated by a reduction in the mitochondrial cytochrome c oxidase subunit 5B ( COX5B ) component of complex IV within adipocytes , which inhibits lipolytic signaling and free-fatty acid mobilization and increases intracellular lipid storage .
10-1	1461-1464	The	event[83]	new[83]	_	_
10-2	1465-1475	macrophage	event[83]	new[83]	_	_
10-3	1476-1488	infiltration	event[83]	new[83]	_	_
10-4	1489-1491	is	_	_	_	_
10-5	1492-1503	perpetuated	_	_	_	_
10-6	1504-1506	by	_	_	_	_
10-7	1507-1508	a	abstract[84]	new[84]	_	_
10-8	1509-1518	reduction	abstract[84]	new[84]	_	_
10-9	1519-1521	in	abstract[84]	new[84]	_	_
10-10	1522-1525	the	abstract[84]|abstract[85]	new[84]|new[85]	_	_
10-11	1526-1539	mitochondrial	abstract[84]|abstract[85]	new[84]|new[85]	_	_
10-12	1540-1550	cytochrome	abstract[84]|abstract[85]	new[84]|new[85]	_	_
10-13	1551-1552	c	abstract[84]|abstract[85]	new[84]|new[85]	_	_
10-14	1553-1560	oxidase	_	_	_	_
10-15	1561-1568	subunit	_	_	_	_
10-16	1569-1571	5B	_	_	_	_
10-17	1572-1573	(	_	_	_	_
10-18	1574-1579	COX5B	object	new	_	_
10-19	1580-1581	)	_	_	_	_
10-20	1582-1591	component	abstract[87]	new[87]	_	_
10-21	1592-1594	of	abstract[87]	new[87]	_	_
10-22	1595-1602	complex	abstract[87]|abstract[88]	new[87]|new[88]	_	_
10-23	1603-1605	IV	abstract[87]|abstract[88]	new[87]|new[88]	_	_
10-24	1606-1612	within	abstract[87]|abstract[88]	new[87]|new[88]	_	_
10-25	1613-1623	adipocytes	abstract[87]|abstract[88]|object	new[87]|new[88]|new	coref	11-4
10-26	1624-1625	,	_	_	_	_
10-27	1626-1631	which	_	_	_	_
10-28	1632-1640	inhibits	_	_	_	_
10-29	1641-1650	lipolytic	abstract[90]	giv[90]	_	_
10-30	1651-1660	signaling	abstract[90]	giv[90]	_	_
10-31	1661-1664	and	_	_	_	_
10-32	1665-1675	free-fatty	event[92]	new[92]	_	_
10-33	1676-1680	acid	substance|event[92]	new|new[92]	_	_
10-34	1681-1693	mobilization	event[92]	new[92]	_	_
10-35	1694-1697	and	_	_	_	_
10-36	1698-1707	increases	_	_	_	_
10-37	1708-1721	intracellular	abstract[94]	new[94]	_	_
10-38	1722-1727	lipid	abstract|abstract[94]	new|new[94]	_	_
10-39	1728-1735	storage	abstract[94]	new[94]	_	_
10-40	1736-1737	.	_	_	_	_

#Text=Hypertrophic expansion of adipocytes promotes stress signals , thereby contributing to immunometabolic dysfunction both locally and systemically .
11-1	1738-1750	Hypertrophic	abstract[95]	new[95]	_	_
11-2	1751-1760	expansion	abstract[95]	new[95]	_	_
11-3	1761-1763	of	abstract[95]	new[95]	_	_
11-4	1764-1774	adipocytes	abstract[95]|object	new[95]|giv	coref	16-46
11-5	1775-1783	promotes	_	_	_	_
11-6	1784-1790	stress	abstract|abstract[98]	giv|new[98]	_	_
11-7	1791-1798	signals	abstract[98]	new[98]	_	_
11-8	1799-1800	,	_	_	_	_
11-9	1801-1808	thereby	_	_	_	_
11-10	1809-1821	contributing	_	_	_	_
11-11	1822-1824	to	_	_	_	_
11-12	1825-1840	immunometabolic	abstract[99]	giv[99]	coref	16-17[155_99]
11-13	1841-1852	dysfunction	abstract[99]	giv[99]	_	_
11-14	1853-1857	both	_	_	_	_
11-15	1858-1865	locally	_	_	_	_
11-16	1866-1869	and	_	_	_	_
11-17	1870-1882	systemically	_	_	_	_
11-18	1883-1884	.	_	_	_	_

#Text=Besides macrophages , dysfunctional adipose tissue can exacerbate immunosenescence by promoting activation and differentiation of immune cells such as B cells ( B lymphocytes ) , nautral killer ( NK ) lymphocytes , regulatory T cells , neutrophils , eosinophils , mast cells , dendritic cells .
12-1	1885-1892	Besides	_	_	_	_
12-2	1893-1904	macrophages	object	giv	_	_
12-3	1905-1906	,	_	_	_	_
12-4	1907-1920	dysfunctional	object[102]	giv[102]	coref	14-21[132_102]
12-5	1921-1928	adipose	abstract|object[102]	giv|giv[102]	coref	14-23
12-6	1929-1935	tissue	object[102]	giv[102]	_	_
12-7	1936-1939	can	_	_	_	_
12-8	1940-1950	exacerbate	_	_	_	_
12-9	1951-1967	immunosenescence	abstract	giv	_	_
12-10	1968-1970	by	_	_	_	_
12-11	1971-1980	promoting	_	_	_	_
12-12	1981-1991	activation	abstract	giv	coref	13-12[122_0]
12-13	1992-1995	and	_	_	_	_
12-14	1996-2011	differentiation	abstract[105]	new[105]	coref	16-35[162_105]
12-15	2012-2014	of	abstract[105]	new[105]	_	_
12-16	2015-2021	immune	abstract[105]|object[106]	new[105]|giv[106]	coref	12-20[107_106]
12-17	2022-2027	cells	abstract[105]|object[106]	new[105]|giv[106]	_	_
12-18	2028-2032	such	abstract[105]	new[105]	_	_
12-19	2033-2035	as	abstract[105]	new[105]	_	_
12-20	2036-2037	B	abstract[105]|object[107]	new[105]|giv[107]	appos	12-23[109_107]
12-21	2038-2043	cells	abstract[105]|object[107]	new[105]|giv[107]	_	_
12-22	2044-2045	(	_	_	_	_
12-23	2046-2047	B	place|object[109]	new|giv[109]	coref|coref	12-32[112_109]|12-32[112_109]
12-24	2048-2059	lymphocytes	object[109]	giv[109]	_	_
12-25	2060-2061	)	_	_	_	_
12-26	2062-2063	,	_	_	_	_
12-27	2064-2071	nautral	abstract[110]	new[110]	appos	12-30[0_110]
12-28	2072-2078	killer	abstract[110]	new[110]	_	_
12-29	2079-2080	(	_	_	_	_
12-30	2081-2083	NK	abstract	giv	coref	15-12
12-31	2084-2085	)	_	_	_	_
12-32	2086-2097	lymphocytes	object[112]	giv[112]	coref	14-4[126_112]
12-33	2098-2099	,	object[112]	giv[112]	_	_
12-34	2100-2110	regulatory	object[112]	giv[112]	_	_
12-35	2111-2112	T	object[112]|person	giv[112]|new	coref	15-9
12-36	2113-2118	cells	object[112]	giv[112]	_	_
12-37	2119-2120	,	object[112]	giv[112]	_	_
12-38	2121-2132	neutrophils	object[112]|abstract	giv[112]|new	coref	14-54
12-39	2133-2134	,	object[112]	giv[112]	_	_
12-40	2135-2146	eosinophils	object[112]|abstract	giv[112]|new	_	_
12-41	2147-2148	,	object[112]	giv[112]	_	_
12-42	2149-2153	mast	object[112]	giv[112]	_	_
12-43	2154-2159	cells	object[112]	giv[112]	_	_
12-44	2160-2161	,	object[112]	giv[112]	_	_
12-45	2162-2171	dendritic	object[112]	giv[112]	_	_
12-46	2172-2177	cells	object[112]	giv[112]	_	_
12-47	2178-2179	.	_	_	_	_

#Text=Immune cell accumulation in AT induces pro-inflammatory cytokine release leads to inflammasome activation and formation of crown-like structure .
13-1	2180-2186	Immune	abstract[117]	giv[117]	_	_
13-2	2187-2191	cell	place|abstract[117]	new|giv[117]	coref	14-48
13-3	2192-2204	accumulation	abstract[117]	giv[117]	_	_
13-4	2205-2207	in	abstract[117]	giv[117]	_	_
13-5	2208-2210	AT	abstract[117]	giv[117]	_	_
13-6	2211-2218	induces	abstract[117]|abstract|event[120]	giv[117]|new|giv[120]	coref|coref	14-39[0_120]|14-39[0_120]
13-7	2219-2235	pro-inflammatory	abstract[117]|event[120]	giv[117]|giv[120]	_	_
13-8	2236-2244	cytokine	abstract[117]|abstract|event[120]	giv[117]|new|giv[120]	_	_
13-9	2245-2252	release	abstract[117]|event[120]	giv[117]|giv[120]	_	_
13-10	2253-2258	leads	_	_	_	_
13-11	2259-2261	to	_	_	_	_
13-12	2262-2274	inflammasome	abstract|abstract[122]	new|giv[122]	coref|coref	14-43[141_122]|14-43[141_122]
13-13	2275-2285	activation	abstract[122]	giv[122]	_	_
13-14	2286-2289	and	_	_	_	_
13-15	2290-2299	formation	event[123]	new[123]	_	_
13-16	2300-2302	of	event[123]	new[123]	_	_
13-17	2303-2313	crown-like	event[123]|abstract[124]	new[123]|new[124]	_	_
13-18	2314-2323	structure	event[123]|abstract[124]	new[123]|new[124]	_	_
13-19	2324-2325	.	_	_	_	_

#Text=The function of immune cells have been investigated in obesity , however some studies suggest that the pro-inflammatory microenvironment of aged murine adipose tissue , characterized by TNF-α , IFN-γ , IL-6 and prostaglandin E2 ( PGE2 ) release , could promote NFκB activation consequently modulate dendritic cell function , also can activate neutrophils .
14-1	2326-2329	The	abstract[125]	new[125]	coref	14-47[143_125]
14-2	2330-2338	function	abstract[125]	new[125]	_	_
14-3	2339-2341	of	abstract[125]	new[125]	_	_
14-4	2342-2348	immune	abstract[125]|object[126]	new[125]|giv[126]	coref	15-8[147_126]
14-5	2349-2354	cells	abstract[125]|object[126]	new[125]|giv[126]	_	_
14-6	2355-2359	have	_	_	_	_
14-7	2360-2364	been	_	_	_	_
14-8	2365-2377	investigated	_	_	_	_
14-9	2378-2380	in	_	_	_	_
14-10	2381-2388	obesity	abstract	new	_	_
14-11	2389-2390	,	_	_	_	_
14-12	2391-2398	however	_	_	_	_
14-13	2399-2403	some	abstract[128]	new[128]	_	_
14-14	2404-2411	studies	abstract[128]	new[128]	_	_
14-15	2412-2419	suggest	_	_	_	_
14-16	2420-2424	that	_	_	_	_
14-17	2425-2428	the	abstract[129]	new[129]	_	_
14-18	2429-2445	pro-inflammatory	abstract[129]	new[129]	_	_
14-19	2446-2462	microenvironment	abstract[129]	new[129]	_	_
14-20	2463-2465	of	abstract[129]	new[129]	_	_
14-21	2466-2470	aged	abstract[129]|object[132]	new[129]|giv[132]	coref	16-14[153_132]
14-22	2471-2477	murine	abstract[129]|abstract|object[132]	new[129]|new|giv[132]	_	_
14-23	2478-2485	adipose	abstract[129]|abstract|object[132]	new[129]|giv|giv[132]	coref	16-14
14-24	2486-2492	tissue	abstract[129]|object[132]	new[129]|giv[132]	_	_
14-25	2493-2494	,	_	_	_	_
14-26	2495-2508	characterized	_	_	_	_
14-27	2509-2511	by	_	_	_	_
14-28	2512-2517	TNF-α	abstract|abstract[134]	giv|giv[134]	_	_
14-29	2518-2519	,	abstract[134]	giv[134]	_	_
14-30	2520-2525	IFN-γ	abstract[134]|object	giv[134]|new	_	_
14-31	2526-2527	,	abstract[134]	giv[134]	_	_
14-32	2528-2532	IL-6	abstract[134]|abstract	giv[134]|giv	_	_
14-33	2533-2536	and	abstract[134]	giv[134]	_	_
14-34	2537-2550	prostaglandin	abstract[134]|abstract[137]	giv[134]|new[137]	_	_
14-35	2551-2553	E2	abstract[134]|abstract[137]	giv[134]|new[137]	_	_
14-36	2554-2555	(	_	_	_	_
14-37	2556-2560	PGE2	object	new	_	_
14-38	2561-2562	)	_	_	_	_
14-39	2563-2570	release	event	giv	_	_
14-40	2571-2572	,	_	_	_	_
14-41	2573-2578	could	_	_	_	_
14-42	2579-2586	promote	_	_	_	_
14-43	2587-2591	NFκB	abstract|abstract[141]	giv|giv[141]	_	_
14-44	2592-2602	activation	abstract[141]	giv[141]	_	_
14-45	2603-2615	consequently	_	_	_	_
14-46	2616-2624	modulate	_	_	_	_
14-47	2625-2634	dendritic	abstract[143]	giv[143]	_	_
14-48	2635-2639	cell	object|abstract[143]	giv|giv[143]	coref	16-36
14-49	2640-2648	function	abstract[143]	giv[143]	_	_
14-50	2649-2650	,	_	_	_	_
14-51	2651-2655	also	_	_	_	_
14-52	2656-2659	can	_	_	_	_
14-53	2660-2668	activate	_	_	_	_
14-54	2669-2680	neutrophils	abstract	giv	_	_
14-55	2681-2682	.	_	_	_	_

#Text=Controversially , the pro-inflammatory state can inhibit regulatory T cells and NK lymphocytes , and also impair anti-inflammatory defense .
15-1	2683-2698	Controversially	_	_	_	_
15-2	2699-2700	,	_	_	_	_
15-3	2701-2704	the	abstract[145]	new[145]	_	_
15-4	2705-2721	pro-inflammatory	abstract[145]	new[145]	_	_
15-5	2722-2727	state	abstract[145]	new[145]	_	_
15-6	2728-2731	can	_	_	_	_
15-7	2732-2739	inhibit	_	_	_	_
15-8	2740-2750	regulatory	object[147]	giv[147]	coref	16-48[166_147]
15-9	2751-2752	T	person|object[147]	giv|giv[147]	_	_
15-10	2753-2758	cells	object[147]	giv[147]	_	_
15-11	2759-2762	and	object[147]	giv[147]	_	_
15-12	2763-2765	NK	object[147]|abstract	giv[147]|giv	_	_
15-13	2766-2777	lymphocytes	object[147]	giv[147]	_	_
15-14	2778-2779	,	_	_	_	_
15-15	2780-2783	and	_	_	_	_
15-16	2784-2788	also	_	_	_	_
15-17	2789-2795	impair	_	_	_	_
15-18	2796-2813	anti-inflammatory	abstract[149]	new[149]	_	_
15-19	2814-2821	defense	abstract[149]	new[149]	_	_
15-20	2822-2823	.	_	_	_	_

#Text=Taken together , the chronic inflammatory environment promoted by aging can contribute to adipose tissue and skeletal muscle dysfunction and consequently leads to a feedback loop that perpetuates adipose inflammation and redistribution , impairs progenitor cell differentiation and leads to cellular dysfunction and death of adipocytes and neighboring cells such as skeletal muscle cells .
16-1	2824-2829	Taken	_	_	_	_
16-2	2830-2838	together	_	_	_	_
16-3	2839-2840	,	_	_	_	_
16-4	2841-2844	the	abstract[150]	giv[150]	_	_
16-5	2845-2852	chronic	abstract[150]	giv[150]	_	_
16-6	2853-2865	inflammatory	abstract[150]	giv[150]	_	_
16-7	2866-2877	environment	abstract[150]	giv[150]	_	_
16-8	2878-2886	promoted	_	_	_	_
16-9	2887-2889	by	_	_	_	_
16-10	2890-2895	aging	abstract	giv	coref	17-57
16-11	2896-2899	can	_	_	_	_
16-12	2900-2910	contribute	_	_	_	_
16-13	2911-2913	to	_	_	_	_
16-14	2914-2921	adipose	abstract|object[153]	giv|giv[153]	coref|coref	16-29|16-29
16-15	2922-2928	tissue	object[153]	giv[153]	_	_
16-16	2929-2932	and	_	_	_	_
16-17	2933-2941	skeletal	abstract[155]	giv[155]	coref	16-41[163_155]
16-18	2942-2948	muscle	object|abstract[155]	new|giv[155]	coref	16-53
16-19	2949-2960	dysfunction	abstract[155]	giv[155]	_	_
16-20	2961-2964	and	_	_	_	_
16-21	2965-2977	consequently	_	_	_	_
16-22	2978-2983	leads	_	_	_	_
16-23	2984-2986	to	_	_	_	_
16-24	2987-2988	a	abstract[157]	new[157]	_	_
16-25	2989-2997	feedback	abstract|abstract[157]	new|new[157]	_	_
16-26	2998-3002	loop	abstract[157]	new[157]	_	_
16-27	3003-3007	that	_	_	_	_
16-28	3008-3019	perpetuates	_	_	_	_
16-29	3020-3027	adipose	abstract|abstract[159]	giv|giv[159]	coref|coref	17-4[169_159]|17-4[169_159]
16-30	3028-3040	inflammation	abstract[159]	giv[159]	_	_
16-31	3041-3044	and	_	_	_	_
16-32	3045-3059	redistribution	abstract	new	_	_
16-33	3060-3061	,	_	_	_	_
16-34	3062-3069	impairs	_	_	_	_
16-35	3070-3080	progenitor	abstract[162]	giv[162]	_	_
16-36	3081-3085	cell	place|abstract[162]	giv|giv[162]	_	_
16-37	3086-3101	differentiation	abstract[162]	giv[162]	_	_
16-38	3102-3105	and	_	_	_	_
16-39	3106-3111	leads	_	_	_	_
16-40	3112-3114	to	_	_	_	_
16-41	3115-3123	cellular	abstract[163]	giv[163]	_	_
16-42	3124-3135	dysfunction	abstract[163]	giv[163]	_	_
16-43	3136-3139	and	_	_	_	_
16-44	3140-3145	death	event[164]	new[164]	_	_
16-45	3146-3148	of	event[164]	new[164]	_	_
16-46	3149-3159	adipocytes	event[164]|object	new[164]|giv	_	_
16-47	3160-3163	and	_	_	_	_
16-48	3164-3175	neighboring	object[166]	giv[166]	ana	17-46[0_166]
16-49	3176-3181	cells	object[166]	giv[166]	_	_
16-50	3182-3186	such	object[166]	giv[166]	_	_
16-51	3187-3189	as	object[166]	giv[166]	_	_
16-52	3190-3198	skeletal	object[166]	giv[166]	_	_
16-53	3199-3205	muscle	object[166]|object	giv[166]|giv	coref	17-6[170_0]
16-54	3206-3211	cells	object[166]	giv[166]	_	_
16-55	3212-3213	.	_	_	_	_

#Text=The effects of inflammation on skeletal muscle is also related to the effects of inflammatory mediators on muscle protein metabolism ( muscle protein breakdown and synthesis ) ; however , way in which the inflammatory factors can induce muscle wasting and the extent to which they do so remains a largely unexplored area of research in aging .
17-1	3214-3217	The	abstract[168]	new[168]	_	_
17-2	3218-3225	effects	abstract[168]	new[168]	_	_
17-3	3226-3228	of	abstract[168]	new[168]	_	_
17-4	3229-3241	inflammation	abstract[168]|abstract[169]	new[168]|giv[169]	_	_
17-5	3242-3244	on	abstract[168]|abstract[169]	new[168]|giv[169]	_	_
17-6	3245-3253	skeletal	abstract[168]|abstract[169]|object[170]	new[168]|giv[169]|giv[170]	coref	17-18[0_170]
17-7	3254-3260	muscle	abstract[168]|abstract[169]|object[170]	new[168]|giv[169]|giv[170]	_	_
17-8	3261-3263	is	_	_	_	_
17-9	3264-3268	also	_	_	_	_
17-10	3269-3276	related	_	_	_	_
17-11	3277-3279	to	_	_	_	_
17-12	3280-3283	the	abstract[171]	new[171]	_	_
17-13	3284-3291	effects	abstract[171]	new[171]	_	_
17-14	3292-3294	of	abstract[171]	new[171]	_	_
17-15	3295-3307	inflammatory	abstract[171]|person[172]	new[171]|new[172]	_	_
17-16	3308-3317	mediators	abstract[171]|person[172]	new[171]|new[172]	_	_
17-17	3318-3320	on	abstract[171]|person[172]	new[171]|new[172]	_	_
17-18	3321-3327	muscle	abstract[171]|person[172]|object|abstract[175]	new[171]|new[172]|giv|new[175]	coref|coref	17-22|17-22
17-19	3328-3335	protein	abstract[171]|person[172]|substance|abstract[175]	new[171]|new[172]|giv|new[175]	coref	17-23
17-20	3336-3346	metabolism	abstract[171]|person[172]|abstract[175]	new[171]|new[172]|new[175]	_	_
17-21	3347-3348	(	_	_	_	_
17-22	3349-3355	muscle	object	giv	coref	17-39
17-23	3356-3363	protein	substance	giv	_	_
17-24	3364-3373	breakdown	_	_	_	_
17-25	3374-3377	and	_	_	_	_
17-26	3378-3387	synthesis	_	_	_	_
17-27	3388-3389	)	_	_	_	_
17-28	3390-3391	;	_	_	_	_
17-29	3392-3399	however	abstract[178]	new[178]	_	_
17-30	3400-3401	,	abstract[178]	new[178]	_	_
17-31	3402-3405	way	abstract[178]	new[178]	_	_
17-32	3406-3408	in	_	_	_	_
17-33	3409-3414	which	_	_	_	_
17-34	3415-3418	the	abstract[179]	giv[179]	_	_
17-35	3419-3431	inflammatory	abstract[179]	giv[179]	_	_
17-36	3432-3439	factors	abstract[179]	giv[179]	_	_
17-37	3440-3443	can	_	_	_	_
17-38	3444-3450	induce	_	_	_	_
17-39	3451-3457	muscle	object	giv	_	_
17-40	3458-3465	wasting	_	_	_	_
17-41	3466-3469	and	_	_	_	_
17-42	3470-3473	the	abstract[181]	new[181]	_	_
17-43	3474-3480	extent	abstract[181]	new[181]	_	_
17-44	3481-3483	to	_	_	_	_
17-45	3484-3489	which	_	_	_	_
17-46	3490-3494	they	object	giv	_	_
17-47	3495-3497	do	_	_	_	_
17-48	3498-3500	so	_	_	_	_
17-49	3501-3508	remains	_	_	_	_
17-50	3509-3510	a	abstract[183]	new[183]	_	_
17-51	3511-3518	largely	abstract[183]	new[183]	_	_
17-52	3519-3529	unexplored	abstract[183]	new[183]	_	_
17-53	3530-3534	area	abstract[183]	new[183]	_	_
17-54	3535-3537	of	abstract[183]	new[183]	_	_
17-55	3538-3546	research	abstract[183]|abstract[184]	new[183]|new[184]	_	_
17-56	3547-3549	in	abstract[183]|abstract[184]	new[183]|new[184]	_	_
17-57	3550-3555	aging	abstract[183]|abstract[184]|abstract	new[183]|new[184]|giv	_	_
17-58	3556-3557	.	_	_	_	_
